Close
Nordic 9Nordic 9

Aglaia BioMedical Ventures (investor - Venture Capital)

Netherlands aglaia-biomedical.com
See something wrong or missing? Let us know
Offices:Utrecht
Average round investment:17.4M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: Netherlands Sapreme
Mostly invests in: Netherlands Netherlands (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Aglaia BioMedical Ventures

Name Criteria
Italy Panakès Partners
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany SHS Capital
82%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United States Dolby Family Ventures
81%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Netherlands
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
United States JJDC - Johnson & Johnson
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Italy AurorA Science
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Jaquet Partners
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
France Siparex
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland Essential Investments
80%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Switzerland SkyViews Life Science
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Belgium White Fund
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Top